
TY  - JOUR
TI  - Abstracts
JO  - Nephrology
VL  - 13
IS  - s3
SN  - 1320-5358
UR  - https://doi.org/10.1111/j.1440-1797.2008.001013.x
DO  - doi:10.1111/j.1440-1797.2008.001013.x
SP  - A99
EP  - A158
PY  - 2008
ER  - 

TY  - JOUR
TI  - Poster Sessions
JO  - Allergy
JA  - Allergy
VL  - 68
IS  - s97
SN  - 0105-4538
UR  - https://doi.org/10.1111/all.12251
DO  - doi:10.1111/all.12251
SP  - 337
EP  - 497
PY  - 2013
ER  - 

TY  - JOUR
AU  - Malchesky, Paul S.
TI  - Artificial Organs 2018: A Year in Review
JO  - Artificial Organs
JA  - Artif Organs
VL  - 43
IS  - 3
SN  - 0160-564X
UR  - https://doi.org/10.1111/aor.13428
DO  - doi:10.1111/aor.13428
SP  - 288
EP  - 317
KW  - artificial oxygen carriers
KW  - bioengineering
KW  - blood pumps
KW  - cardiac
KW  - cardiopulmonary
KW  - dialysis
KW  - extracorporeal membrane oxygenation
KW  - functional electrical stimulation
KW  - medical devices
KW  - membrane oxygenation
KW  - organ preservation
KW  - orthopedic
KW  - pulmonary
KW  - renal
KW  - tissue engineering
KW  - transplantation
KW  - valves
KW  - vascular
KW  - vision
PY  - 2019
AB  - Abstract In this Editor's Review, articles published in 2018 are organized by category and summarized. We provide a brief reflection of the research and progress in artificial organs intended to advance and better human life while providing insight for continued application of these technologies and methods. Artificial Organs continues in the original mission of its founders ?to foster communications in the field of artificial organs on an international level.? Artificial Organs continues to publish developments and clinical applications of artificial organ technologies in this broad and expanding field of organ Replacement, Recovery, and Regeneration from all over the world. Peer-reviewed special issues this year included contributions from the 13th International Conference on Pediatric Mechanical Circulatory Support Systems and Pediatric Cardiopulmonary Perfusion edited by Dr. Akif Undar, and the 25th Congress of the International Society for Mechanical Circulatory Support edited by Dr. Marvin Slepian. Additionally, many editorials highlighted the worldwide survival differences in hemodialysis and perspectives on mechanical circulatory support and stem cell therapies for cardiac support. We take this time also to express our gratitude to our authors for offering their work to this journal. We offer our very special thanks to our reviewers who give so generously of time and expertise to review, critique, and especially provide meaningful suggestions to the author's work whether eventually accepted or rejected. Without these excellent and dedicated reviewers the quality expected from such a journal could not be possible. We also express our special thanks to our Publisher, John Wiley & Sons for their expert attention and support in the production and marketing of Artificial Organs. We look forward to reporting further advances in the coming years.
ER  - 

TY  - JOUR
TI  - Abstracts: Annual Scientific Meeting of the European College of Veterinary Ophthalmologists, London, UK May 15–18, 2014
JO  - Veterinary Ophthalmology
JA  - Vet Ophthalmol
VL  - 17
IS  - 6
SN  - 1463-5216
UR  - https://doi.org/10.1111/vop.12191
DO  - doi:10.1111/vop.12191
SP  - E16
EP  - E30
PY  - 2014
ER  - 

TY  - JOUR
TI  - Colorectal Surgery Program Abstracts
JO  - ANZ Journal of Surgery
JA  - ANZ J Surg
VL  - 84
IS  - S1
SN  - 1445-1433
UR  - https://doi.org/10.1111/ans.12609
DO  - doi:10.1111/ans.12609
SP  - 30
EP  - 52
PY  - 2014
ER  - 

TY  - JOUR
TI  - FREE COMMUNICATIONS  POSTER COMMUNICATIONS
JO  - Nephrology
VL  - 10
IS  - s1
SN  - 1320-5358
UR  - https://doi.org/10.1111/j.1440-1797.2005.00420.x
DO  - doi:10.1111/j.1440-1797.2005.00420.x
SP  - A117
EP  - A232
PY  - 2005
ER  - 

TY  - JOUR
TI  - Wissenschaftliches Programm
JO  - Somnologie
VL  - 8
IS  - s1
SN  - 1432-9123
UR  - https://doi.org/10.1111/j.1439-054X.2004.00027.x
DO  - doi:10.1111/j.1439-054X.2004.00027.x
SP  - 13
EP  - 82
PY  - 2004
ER  - 

TY  - JOUR
TI  - 14th ISN MEETING, MONTPELLJER, FRANCE
JO  - Journal of Neurochemistry
VL  - 61
IS  - s1
SN  - 0022-3042
UR  - https://doi.org/10.1111/j.1471-4159.1993.tb13441.x
DO  - doi:10.1111/j.1471-4159.1993.tb13441.x
SP  - 1
EP  - 285
PY  - 1993
ER  - 

TY  - JOUR
TI  - Focus Group
JO  - Transplant International
JA  - Transpl Int
VL  - 32
IS  - S2
SN  - 0934-0874
UR  - https://doi.org/10.1111/tri.13513
DO  - doi:10.1111/tri.13513
SP  - 127
EP  - 158
PY  - 2019
ER  - 

TY  - JOUR
TI  - Poster Presentations
JO  - Acta Physiologica
JA  - Acta Physiol
VL  - 210
IS  - s695
SN  - 1748-1708
UR  - https://doi.org/10.1111/apha.12270
DO  - doi:10.1111/apha.12270
SP  - 82
EP  - 228
PY  - 2014
ER  - 

TY  - JOUR
TI  - Mini Oral Abstracts
JO  - Nephrology
JA  - Nephrology
VL  - 21
IS  - S2
SN  - 1320-5358
UR  - https://doi.org/10.1111/nep.12887
DO  - doi:10.1111/nep.12887
SP  - 58
EP  - 149
PY  - 2016
ER  - 

TY  - JOUR
TI  - Current awareness: Pharmacoepidemiology and drug safety
JO  - Pharmacoepidemiology and Drug Safety
JA  - Pharmacoepidem. Drug Safe.
VL  - 19
IS  - 9
SN  - 1053-8569
UR  - https://doi.org/10.1002/pds.1854
DO  - doi:10.1002/pds.1854
SP  - i
EP  - xiii
PY  - 2010
AB  - Abstract In order to keep subscribers up-to-date with the latest developments in their field, John Wiley  2 General; 3 Anti-infective Agents; 4 Cardiovascular System Agents; 5 CNS Depressive Agents; 6 Non-steroidal Anti-inflammatory Agents; 7 CNS Agents; 8 Anti-neoplastic Agents; 9 Haematological Agents; 10 Neuroregulator-Blocking Agents; 11 Dermatological Agents; 12 Immunosuppressive Agents; 13 Autonomic Agents; 14 Respiratory System Agents; 15 Neuromuscular Agents; 16 Reproductive System Agents; 17 Gastrointestinal System Agents; 18 Anti-inflammatory Agents - Steroidal; 19 Teratogens/fetal exposure; 20 Antidiabetic Agents; 21 Contrast Agents; 22 Bone Conservation Agents; 23 Others. Within each section, articles are listed in alphabetical order with respect to author. If, in the preceding period, no publications are located relevant to any one of these headings, that section will be omitted.
ER  - 

TY  - JOUR
TI  - Abstracts OAS
JO  - Allergy
JA  - Allergy
VL  - 73
IS  - S105
SN  - 0105-4538
UR  - https://doi.org/10.1111/all.13535
DO  - doi:10.1111/all.13535
SP  - 3
EP  - 115
PY  - 2018
ER  - 

TY  - JOUR
TI  - 2003 Meeting of the Peripheral Nerve Society
JO  - Journal of the Peripheral Nervous System
VL  - 8
IS  - s1
SN  - 1085-9489
UR  - https://doi.org/10.1046/j.1529-8027.8.s1.1.x
DO  - doi:10.1046/j.1529-8027.8.s1.1.x
SP  - 1
EP  - 78
PY  - 2003
ER  - 

TY  - JOUR
TI  - Poster Session 1
JO  - European Journal of Heart Failure
JA  - Eur J Heart Fail
VL  - 16
IS  - s2
SN  - 1388-9842
UR  - https://doi.org/10.1002/ejhf.93_4
DO  - doi:10.1002/ejhf.93_4
SP  - 19
EP  - 98
PY  - 2014
ER  - 

TY  - JOUR
AU  - Ouali Alami, Najwa
AU  - Schurr, Christine
AU  - Olde Heuvel, Florian
AU  - Tang, Linyun
AU  - Li, Qian
AU  - Tasdogan, Alpaslan
AU  - Kimbara, Atsushi
AU  - Nettekoven, Matthias
AU  - Ottaviani, Giorgio
AU  - Raposo, Catarina
AU  - Röver, Stephan
AU  - Rogers-Evans, Mark
AU  - Rothenhäusler, Benno
AU  - Ullmer, Christoph
AU  - Fingerle, Jürgen
AU  - Grether, Uwe
AU  - Knuesel, Irene
AU  - Boeckers, Tobias M
AU  - Ludolph, Albert
AU  - Wirth, Thomas
AU  - Roselli, Francesco
AU  - Baumann, Bernd
C7  - e98697
TI  - NF-κB activation in astrocytes drives a stage-specific beneficial neuroimmunological response in ALS
JO  - The EMBO Journal
JA  - EMBO J
VL  - 37
IS  - 16
SN  - 0261-4189
UR  - https://doi.org/10.15252/embj.201798697
DO  - doi:10.15252/embj.201798697
SP  - e98697
KW  - amyotrophic lateral sclerosis
KW  - astrocytes
KW  - CB2 receptor agonist
KW  - NF-κB
KW  - Wnt
PY  - 2018
AB  - Abstract Astrocytes are involved in non-cell-autonomous pathogenic cascades in amyotrophic lateral sclerosis (ALS); however, their role is still debated. We show that astrocytic NF-?B activation drives microglial proliferation and leukocyte infiltration in the SOD1 (G93A) ALS model. This response prolongs the presymptomatic phase, delaying muscle denervation and decreasing disease burden, but turns detrimental in the symptomatic phase, accelerating disease progression. The transition corresponds to a shift in the microglial phenotype showing two effects that can be dissociated by temporally controlling NF-?B activation. While NF-?B activation in astrocytes induced a Wnt-dependent microglial proliferation in the presymptomatic phase with neuroprotective effects on motoneurons, in later stage, astrocyte NF-?B-dependent microglial activation caused an accelerated disease progression. Notably, suppression of the early microglial response by CB2R agonists had acute detrimental effects. These data identify astrocytes as important regulators of microglia expansion and immune response. Therefore, stage-dependent microglia modulation may be an effective therapeutic strategy in ALS.
ER  - 

TY  - JOUR
TI  - Poster Session Abstracts
JO  - Pediatric Pulmonology
JA  - Pediatr Pulmonol.
VL  - 52
IS  - S47
SN  - 8755-6863
UR  - https://doi.org/10.1002/ppul.23840
DO  - doi:10.1002/ppul.23840
SP  - S214
EP  - S516
PY  - 2017
ER  - 

C7  - pp. 584-658
TI  - Cardiac Regenerative Engineering
SN  - 9780471709077
UR  - https://doi.org/10.1002/9780470116869.ch14
DO  - doi:10.1002/9780470116869.ch14
SP  - 584-658
KW  - cardiac regenerative engineering and cardiac disorders
KW  - Vascular endothelial growth factor (VEGF) A
KW  - antioxidant molecules and therapeutic agents
PY  - 2017
AB  - Summary This chapter contains sections titled: Anatomy and Physiology of the Heart Cardiac Disorders
ER  - 

TY  - JOUR
TI  - Oral Abstracts
JO  - Fundamental & Clinical Pharmacology
JA  - Fundam Clin Pharmacol
VL  - 27
IS  - s1
SN  - 9780471709077
UR  - https://doi.org/10.1111/fcp.12025
DO  - doi:10.1111/fcp.12025
SP  - 1
EP  - 45
PY  - 2013
ER  - 

TY  - JOUR
TI  - Oral Presentations and Posters
JO  - Tissue Antigens
JA  - Tissue Antigens
VL  - 85
IS  - 5
SN  - 9780471709077
UR  - https://doi.org/10.1111/tan.12557
DO  - doi:10.1111/tan.12557
SP  - 301
EP  - 431
PY  - 2015
ER  - 
